The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Clinical trial NCT06523400 · RECRUITING
Trial details
- NCT number
- NCT06523400
- Sponsor
- Lupin Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2026-03-17
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.